All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Pain at its Least | NCIT_C112185 | [A question about an individual's pain at its least.] |
| Dose Reduced | NCIT_C49505 | [An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.] |
| Pain Right Now | NCIT_C112186 | [A question about an individual's pain right now.] |
| Treatment or Medication Received for Pain | NCIT_C112187 | [A question about which treatments or medications an individual is receiving or has received for pain.] |
| Medium | NCIT_C49507 | [Mid-way between small and large in number, quantity, magnitude or extent.] |
| How Much Relief Received from Treatment or Medication | NCIT_C112188 | [A question about how much pain relief an individual is receiving or has received from treatment or medication.] |
| CDKN2A wt Allele | NCIT_C49511 | [Human CDKN2A wild-type allele is located in the vicinity of 9p21 and is approximately 27 kb in length. This allele, which encodes both cyclin-dependent kinase inhibitor 2A protein and and tumor suppressor ARF protein, is involved in cell cycle regulation at the G1 phase. The allele is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene.] |
| CDKN2A Gene | NCIT_C18022 | [This gene functions as a tumor suppressor and transcriptional regulator.] |
| Tinea Infection | NCIT_C112181 | [A skin infection caused by a fungus.] |
| CDKN2B wt Allele | NCIT_C49512 | [Human CDKN2B wild-type allele is located within 9p21 and is approximately 27 kb in length. This allele, which encodes cyclin-dependent kinase 4 inhibitor B protein, plays roles in both the regulation of cell growth and tumor suppression.] |
| CDKN2B Gene | NCIT_C18323 | [This gene is involved in cell cycle regulation and arrest.] |
| Toxic Erythema of Chemotherapy | NCIT_C112182 | [Painful red or purple patches, edematous plaques or blisters on the hands, feet, extremities or intertriginous regions; the onset can occur days to months after receiving chemotherapy.] |
| Erythema | NCIT_C26901 | [Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease.] |
| CDKN2C wt Allele | NCIT_C49513 | [Human CDKN2C wild-type allele is located within 1p32 and is approximately 14 kb in length. This allele, which encodes cyclin-dependent kinase 4 inhibitor C protein, is involved in cellular growth regulation and progression from the G1 phase of the cell cycle.] |
| CDKN2C Gene | NCIT_C24288 | [This gene is involved in cell cycle inhibition and regulation.] |
| Blepharitis | NCIT_C112183 | [Inflammation of the eyelids near the eyelashes.] |
| CDKN3 wt Allele | NCIT_C49514 | [Human CDKN3 wild-type allele is located within 14q22 and is approximately 23 kb in length. This allele, which encodes cyclin-dependent kinase inhibitor 3 protein, may play a role in cell cycle regulation. Defects in CDKN3 allele have been identified in patients with hepatocellular carcinoma (HCC) and the allele is deleted, mutated, or overexpressed in several kinds of cancers.] |
| CDKN3 Gene | NCIT_C24289 | [This gene plays a role in cell cycle regulation.] |
| Have Pain Other Than Everyday Kind of Pain | NCIT_C112184 | [A question about whether an individual has or had pain other than everyday kinds of pain.] |
| CDKN1C wt Allele | NCIT_C49510 | [Human CDKN1C wild-type allele located in the vicinity of 11p15.5 and is approximately 2 kb in length. This allele, which encodes cyclin-dependent kinase inhibitor 1C protein, plays a negative role in the regulation of cellular proliferation by inhibiting several G1 cyclin/Cdk complexes. Mutations of the gene, which generates variant alleles have been implicated in both sporadic cancers and Beckwith-Wiedemann syndrome, suggesting that it is a tumor suppressor candidate.] |